Literature DB >> 33192444

The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders.

Eva Maria Fritz1, Nicolas Singewald1, Dimitri De Bundel2.   

Abstract

Ghrelin is a peptide hormone released by specialized X/A cells in the stomach and activated by acylation. Following its secretion, it binds to ghrelin receptors in the periphery to regulate energy balance, but it also acts on the central nervous system where it induces a potent orexigenic effect. Several types of stressors have been shown to stimulate ghrelin release in rodents, including nutritional stressors like food deprivation, but also physical and psychological stressors such as foot shocks, social defeat, forced immobilization or chronic unpredictable mild stress. The mechanism through which these stressors drive ghrelin release from the stomach lining remains unknown and, to date, the resulting consequences of ghrelin release for stress coping remain poorly understood. Indeed, ghrelin has been proposed to act as a stress hormone that reduces fear, anxiety- and depression-like behaviors in rodents but some studies suggest that ghrelin may - in contrast - promote such behaviors. In this review, we aim to provide a comprehensive overview of the literature on the role of the ghrelin system in stress coping. We discuss whether ghrelin release is more than a byproduct of disrupted energy homeostasis following stress exposure. Furthermore, we explore the notion that ghrelin receptor signaling in the brain may have effects independent of circulating ghrelin and in what way this might influence stress coping in rodents. Finally, we examine how the ghrelin system could be utilized as a therapeutic avenue in stress-related psychiatric disorders (with a focus on anxiety- and trauma-related disorders), for example to develop novel biomarkers for a better diagnosis or new interventions to tackle relapse or treatment resistance in patients.
Copyright © 2020 Fritz, Singewald and De Bundel.

Entities:  

Keywords:  GHSR; PTSD; anxiety disorders; central ghrelin resistance; food intake; ghrelin; stress

Year:  2020        PMID: 33192444      PMCID: PMC7652849          DOI: 10.3389/fnsyn.2020.594484

Source DB:  PubMed          Journal:  Front Synaptic Neurosci        ISSN: 1663-3563


  246 in total

1.  Growth hormone secretagogue receptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memory.

Authors:  Rosie G Albarran-Zeckler; Alicia Faruzzi Brantley; Roy G Smith
Journal:  Behav Brain Res       Date:  2012-03-31       Impact factor: 3.332

2.  RDoC, DSM, and the reflex physiology of fear: A biodimensional analysis of the anxiety disorders spectrum.

Authors:  Peter J Lang; Lisa M McTeague; Margaret M Bradley
Journal:  Psychophysiology       Date:  2016-03       Impact factor: 4.016

3.  Ghrelin, a novel placental-derived hormone.

Authors:  O Gualillo; J Caminos; M Blanco; T Garcìa-Caballero; M Kojima; K Kangawa; C Dieguez; F Casanueva
Journal:  Endocrinology       Date:  2001-02       Impact factor: 4.736

4.  Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus.

Authors:  Yukari Date; Takuya Shimbara; Shuichi Koda; Koji Toshinai; Takanori Ida; Noboru Murakami; Mikiya Miyazato; Koichi Kokame; Yuta Ishizuka; Yasushi Ishida; Haruaki Kageyama; Seiji Shioda; Kenji Kangawa; Masamitsu Nakazato
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

5.  The protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice.

Authors:  Hui-Jie Huang; Xiao-Rong Chen; Qiu-Qin Han; Jing Wang; Adam Pilot; Rui Yu; Qiong Liu; Bing Li; Gen-Cheng Wu; Yan-Qing Wang; Jin Yu
Journal:  Neuropharmacology       Date:  2019-05-16       Impact factor: 5.250

Review 6.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

7.  Ghrelin and leptin levels in children with anxiety disorders.

Authors:  Sevgi Ozmen; Asilay Şeker; Esra Demirci
Journal:  J Pediatr Endocrinol Metab       Date:  2019-10-25       Impact factor: 1.634

8.  Ghrelin octanoylation mediated by an orphan lipid transferase.

Authors:  Jesus A Gutierrez; Patricia J Solenberg; Douglas R Perkins; Jill A Willency; Michael D Knierman; Zhaoyan Jin; Derrick R Witcher; Shuang Luo; Jude E Onyia; John E Hale
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  A possible association between panic disorder and a polymorphism in the preproghrelingene.

Authors:  Caroline Hansson; Kristina Annerbrink; Staffan Nilsson; Jessica Bah; Marie Olsson; Christer Allgulander; Sven Andersch; Ingemar Sjödin; Elias Eriksson; Suzanne L Dickson
Journal:  Psychiatry Res       Date:  2012-10-17       Impact factor: 3.222

10.  The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress.

Authors:  Michael Lutter; Ichiro Sakata; Sherri Osborne-Lawrence; Sherry A Rovinsky; Jason G Anderson; Saendy Jung; Shari Birnbaum; Masashi Yanagisawa; Joel K Elmquist; Eric J Nestler; Jeffrey M Zigman
Journal:  Nat Neurosci       Date:  2008-06-15       Impact factor: 24.884

View more
  7 in total

Review 1.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

2.  Association Between Self-rating Depression Scores and Total Ghrelin and Adipokine Serum Levels in a Large Population-Based Sample.

Authors:  Dirk Alexander Wittekind; Jürgen Kratzsch; Ronald Biemann; Roland Mergl; Steffi Riedel-Heller; Veronika Witte; Arno Villringer; Michael Kluge
Journal:  Front Psychiatry       Date:  2022-05-11       Impact factor: 5.435

3.  Co-Therapy of Pegylated G-CSF and Ghrelin for Enhancing Survival After Exposure to Lethal Radiation.

Authors:  Juliann G Kiang; Min Zhai; Bin Lin; Joan T Smith; Marsha N Anderson; Suping Jiang
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

Review 4.  Gut peptides and the microbiome: focus on ghrelin.

Authors:  Natasha K Leeuwendaal; John F Cryan; Harriët Schellekens
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-04-01       Impact factor: 3.626

5.  Exploratory drive, fear, and anxiety are dissociable and independent components in foraging mice.

Authors:  Daniel E Heinz; Vivian A Schöttle; Paulina Nemcova; Florian P Binder; Tim Ebert; Katharina Domschke; Carsten T Wotjak
Journal:  Transl Psychiatry       Date:  2021-05-26       Impact factor: 6.222

Review 6.  Expression of the growth hormone secretagogue receptor 1a (GHS-R1a) in the brain.

Authors:  Marat I Airapetov; Sergei O Eresko; Andrei A Lebedev; Evgenii R Bychkov; Petr D Shabanov
Journal:  Physiol Rep       Date:  2021-11

7.  An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side.

Authors:  Olesya T Shevchouk; Maximilian Tufvesson-Alm; Elisabet Jerlhag
Journal:  Front Neurosci       Date:  2021-12-09       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.